Literature DB >> 23045408

Patient evaluation of the Echelon foot using the Seattle Prosthesis Evaluation Questionnaire.

Imad Sedki1, Raymond Moore.   

Abstract

BACKGROUND: The introduction of the Echelon prosthetic foot with a hydraulic self-aligning ankle adds improved adaptability to varied terrains and uneven walking surfaces. However, the specific indications for prescribing such components and the potential benefits are yet to be fully established. CASE DESCRIPTION AND METHODS: Nine amputees including three bilateral amputees evaluated their standard prostheses using the Seattle Prosthesis Evaluation Questionnaire. They were then provided with Echelon feet, and they evaluated them after 4 weeks of use. FINDINGS AND OUTCOMES: Improved satisfaction in all categories of use in relation to the Echelon foot with the greatest increase reported by bilateral amputees.
CONCLUSION: The use of prosthetic feet with hydraulic self-aligning ankle improves prosthetic users' satisfaction in general with a particular benefit in bilateral amputees. CLINICAL RELEVANCE: Establish the clinical impact and user satisfaction after using Echelon feet in prosthetic users with different levels of amputations.

Entities:  

Keywords:  Echelon; Prosthesis Evaluation Questionnaire; self-aligning ankle prosthesis

Mesh:

Year:  2012        PMID: 23045408     DOI: 10.1177/0309364612458448

Source DB:  PubMed          Journal:  Prosthet Orthot Int        ISSN: 0309-3646            Impact factor:   1.895


  2 in total

1.  The influence of a hydraulic prosthetic ankle on residual limb loading during sloped walking.

Authors:  Sara R Koehler-McNicholas; Eric A Nickel; Joseph Medvec; Kyle Barrons; Spencer Mion; Andrew H Hansen
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

2.  A biomechanical assessment of hydraulic ankle-foot devices with and without micro-processor control during slope ambulation in trans-femoral amputees.

Authors:  Xuefei Bai; David Ewins; Andrew David Crocombe; Wei Xu
Journal:  PLoS One       Date:  2018-10-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.